All Stories

  1. A new variant of respiratory syncytial virus (RSV)-B was the most common in Italy after the pandemic
  2. Molecular study of the presence and transcriptional activity of HPV in semen
  3. Temporal dynamics and variants of respiratory syncytial virus causing bronchiolitis after COVID-19
  4. NRF2 Antioxidant Response and Interferon-Stimulated Genes Are Differentially Expressed in Respiratory-Syncytial-Virus- and Rhinovirus-Infected Hospitalized Children
  5. Natural Flavonoid Derivatives Have Pan-Coronavirus Antiviral Activity
  6. Multicenter epidemiological investigation and genetic characterization of respiratory syncytial virus and metapneumovirus infections in the pre-pandemic 2018–2019 season in northern and central Italy
  7. Common Microbial Genital Infections and Their Impact on the Innate Immune Response to HPV in Cervical Cells
  8. The non-functional ACE2 isoform, but not the SARS-CoV-2 receptor, is induced as an interferon-stimulated gene, in SARS-CoV-2 infected adults
  9. High frequency of neutralizing antibodies to type I Interferon in HIV-1 patients hospitalized for COVID-19
  10. Comparison by Age of the Local Interferon Response to SARS-CoV-2 Suggests a Role for IFN-ε and -ω
  11. Low lymphocyte count: A clinical severity marker in infants with bronchiolitis
  12. Anti‐IFN‐α/‐ω neutralizing antibodies from COVID‐19 patients correlate with downregulation of IFN response and laboratory biomarkers of disease severity
  13. HPV Vaccination after Primary Treatment of HPV-Related Disease across Different Organ Sites: A Multidisciplinary Comprehensive Review and Meta-Analysis
  14. Bronchiolitis phenotypes identified by latent class analysis may influence the occurrence of respiratory sequelae
  15. Modifiable environmental factors predispose term infants to bronchiolitis but bronchiolitis itself predisposes to respiratory sequelae
  16. Clinical Effects of Oral Bacteriotherapy on Anal HPV Infection and Related Dysplasia in HIV-Positive MSM: Results from the “HPVinHIV” Trial
  17. During the COVID‐19 pandemic where has respiratory syncytial virus gone?
  18. The starting rate for high‐flow nasal cannula oxygen therapy in infants with bronchiolitis: Is clinical judgment enough?
  19. Viral community acquired pneumonia at the emergency department: Report from the pre COVID‐19 age
  20. ACE2 expression is related to the interferon response in airway epithelial cells but is that functional for SARS-CoV-2 entry?
  21. Differential induction of type I and III interferon genes in the upper respiratory tract of patients with coronavirus disease 2019 (COVID-19)
  22. Naringenin is a powerful inhibitor of SARS-CoV-2 infection in vitro
  23. Differential toll like receptor expression in cystic fibrosis patients' airways during rhinovirus infection
  24. No detection of SARS-CoV-2 in cystic fibrosis patients at the Regional (Lazio) Reference Center for CF in Italy
  25. Type I interferons can be detected in respiratory swabs from SARS-Cov-2 infected patients
  26. A single centre study of viral community-acquired pneumonia in children: No evidence of SARS-CoV-2 from October 2019 to March 2020
  27. Insights into the Role of Innate Immunity in Cervicovaginal Papillomavirus Infection from Studies Using Gene-Deficient Mice
  28. Nasal Microbiota in RSV Bronchiolitis
  29. Will children reveal their secret? The Sars-CoV-2 dilemma
  30. Novel Variants of Respiratory Syncytial Virus A ON1 Associated With Increased Clinical Severity of Bronchiolitis
  31. Increased T-helper Cell 2 Response in Infants With Respiratory Syncytial Virus Bronchiolitis Hospitalized Outside Epidemic Peak
  32. Variability in the glycoprotein G gene of RSV-A ON1 strains causing bronchiolitis
  33. Differential interferon gene expression in bronchiolitis caused by respiratory syncytial virus-A genotype ON1
  34. Cervical determinants of anal HPV infection and high-grade anal lesions in women: a collaborative pooled analysis
  35. Increased expression of IL-32 correlates with IFN-γ, Th1 and Tc1 in virologically suppressed HIV-1-infected patients
  36. Respiratory syncytial virus
  37. How Respiratory Syncytial Virus Genotypes Influence the Clinical Course in Infants Hospitalized for Bronchiolitis
  38. Analysis of the immune response in infants hospitalized with viral bronchiolitis shows different Th1/Th2 profiles associated with respiratory syncytial virus and human rhinovirus
  39. Interferon lambda receptor 1 (IFNL1R) transcript is highly expressed in rhinovirus bronchiolitis and correlates with disease severity
  40. CD38 modulates respiratory syncytial virus-driven proinflammatory processes in human monocyte-derived dendritic cells
  41. Acute bronchiolitis: Influence of viral co-infection in infants hospitalized over 12 consecutive epidemic seasons
  42. Adaptive immune response in RSV and RV bronchiolitis infants
  43. Consolidation of molecular testing in clinical virology
  44. Bronchiolitis:analysis of 10 consecutive epidemiological seasons
  45. Molecular epidemiology and genetic diversity of human rhinovirus affecting hospitalized children in Rome
  46. High detection rate of human papillomavirus in anal brushings from women attending a proctology clinic
  47. Evaluation of interleukin 28B single nucleotide polymorphisms in infants suffering from bronchiolitis
  48. Virological and clinical characterization of respiratory infections in children attending an emergency department during the first autumn-winter circulation of pandemic A (HINI) 2009 influenza virus
  49. Evaluation of viral load in infants hospitalized with bronchiolitis caused by respiratory syncytial virus
  50. Rhinovirus frequently detected in elderly adults attending an emergency department
  51. Rhinovirus bronchiolitis and recurrent wheezing: 1-year follow-up
  52. Pandemic 2009 H1N1 Influenza Virus Is Resistant to the Antiviral Activity of Several Interferon Alpha Subtypes
  53. In Vitro Sensitivity of Human Metapneumovirus to Type I Interferons
  54. Incidence and predisposing factors for severe disease in previously healthy term infants experiencing their first episode of bronchiolitis
  55. Virological diagnosis of respiratory virus infection in patients attending an emergency department during the influenza season
  56. Respiratory syncytial virus, human bocavirus and rhinovirus bronchiolitis in infants
  57. Detection of Human Papillomavirus and Adenovirus in Benign and Malignant Lesions of the Larynx
  58. Human Papilloma Virus DNA Detection, p53 and Ki67 Expression in Penile Verrucous and Squamous Cell Carcinomas in the Same Patient
  59. Presence and environmental circulation of enteric viruses in three different wastewater treatment plants
  60. Gene Expression of Nucleic Acid-Sensing Pattern Recognition Receptors in Children Hospitalized for Respiratory Syncytial Virus-Associated Acute Bronchiolitis
  61. Human Papillomaviruses and genital co-infections in gynaecological outpatients
  62. Type-specific human papillomavirus-DNA load in anal infection in HIV-positive men
  63. Human bocavirus infection in hospitalized children in Italy
  64. A BRIEF COMMUNICATION
  65. Markers of human papillomavirus infection and their correlation with cervical dysplasia in human immunodeficiency virus-positive women
  66. Detection and typing by molecular techniques of respiratory viruses in children hospitalized for acute respiratory infection in Rome, Italy
  67. The Effects of Prolonged Treatment with Zidovudine, Lamivudine, and Abacavir on a T-Lymphoblastoid Cell Line
  68. Direct sequencing of HPV DNA detected in gynaecologic outpatients in Rome, Italy
  69. Human Papillomavirus-32-Positive Extragenital Bowenoid Papulosis (BP) in a HIV Patient With Typical Genital BP Localization
  70. The distance between the 3′-pyrimidine-rich tract and the AUG codon modulates internal initiation of translation of hepatitis A virus RNA
  71. Association of Human Papillomavirus Type 11 with Carcinoma of the Penis
  72. The detection of human papillomavirus DNA in skin tags
  73. Mutational analysis of the 3′-terminal extra-cistronic region of poliovirus RNA: secondary structure is not the only requirement for minus strand RNA replication
  74. Role of the pyrimidine-rich tract on the translation of ‘chimeric’ polio-hepatitis A mRNAs with engineered 5′-terminal untranslated regions
  75. Antigenic and Biochemical Characterization of Poliovirus Type 2 Isolated from Two Cases of Paralytic Disease